Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre

European Respiratory Journal

Volumn 27, Issue 5, 2006, Pages 937-943

  Proesmans, M ^a   Balinska Miskiewicz, W ^b   Dupont, L ^a   Bossuyt, X ^a   Verhaegen, J ^a   Hoiby N ^c   de Boeck, K ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Anti pseudomonal antibodies; Chronic lung infection; Cystic fibrosis; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; HEALTH STATUS; HUMAN; IMMUNOLOGICAL PARAMETERS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 33845512919     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00100805     Document Type: Article

References (30)

1. Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001; 32: 277-287.
2. Høiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of pseudomonas aeruginosa and the humoral immune response. Acta Pathol Microbiol Scand 1974; 82: 551-558.
3. Høiby N, Flensborg EW, Beck B, Frijs B, Jacobsen SV, Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic i significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis 1977; 58: 65-79.
4. Doring G, Conway SP, Heijerman HG, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000; 16: 749-767.
5. Johansen HK, Høiby N. Seasonal onset of initial colonization and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 1992; 47: 109-111.
6. Frederiksen B, Koch C, Høiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997; 23: 330-335.
7. Lee TWR, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cystic Fibros 2003; 2: 29-34.
8. Burns JL, Gibson RL, McNamara S, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001; 183: 444-452.
9. Rosenfeld M, Emerson J, Accurso F, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999; 28: 321-328.
10. Pier GB. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. J Infect Dis 1985; 151: 575-580.
11. Høiby N. Antibodies against Pseudomonas aeruginosa in patients with bronchiectasis: helpful or harmful? Thorax 2001; 56: 667-668.
12. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998; 132: 589-595.
13. Population variation of common cystic fibrosis mutations. The Cystic Fibrosis Genetic Analysis Consortium. Human Mutat 1994; 4: 167-177.
14. Wilschanski M, Zielenski J, Markiewicz D, et al. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr 1995; 127: 705-710.
15. Koch C, Cuppens H, Rainisio M, et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 2001; 31: 1-12.
16. The chromosome 7 project. Department of Genetics, hospital for sick children, Toronto, Canada. http://www.genet.sickkids.on.ca/ Date last updated: November 21, 2005. Date last accessed: February 28, 2006.
17. Høiby N, Collins MT, Espersen F, Hertz JB, Hoff GE, Schiotz PO. Taxonomic application of crossed immuno-electrophoresis. Internat J Syst Bacteriol 1987; 37: 229-240.
18. Pedersen SS, Espersen F, Høiby N. Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay. J Clin Microbiol 1987, 24: 1830-1836.
19. Pressler T, Pedersen SS, Espersen F, Høiby N, Koch C. IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Pseudomonas aeruginosa infection investigated by ELISA. Clin Exp Immunol 1990; 81: 428-434.
20. American Thoracic Society. Standardization of Spirometry. Am J Respir Crit Care Med 1995; 152: 1107-1136.
21. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725-734.
22. Rosenfeld M, Pepe MS, Longton G, Emerson J, FitzSimmons S, Morgan W. Effect of choice of reference equation on analysis of pulmonary function in cystic fibrosis patients. Pediatr Pulmonol 2001; 31: 227-237.
23. Hernandez M, Castellet J, Narval JL, et al. Curvas y tablas de Crecimiento [Growth charts and tables]. Fundación F Obregozo, Bilbao. Ed Garsi, Madrid, 1988; pp. 1-26.
24. Høiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 2005; 4: 49-54.
25. Brett MM, Ghonheim AT, Littlewood JM. Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study. J Clin Microbiol 1988; 26: 1565-1570.
26. Shand GH, Pedersen SS, Tilling R, Brown MR, Høiby N. Use of immunoblot detection of serum antibodies in the diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. J Med Microbiol 1988; 27: 168-177.
27. Brett MM, Simmonds EJ, Ghonheim AT, Littlewood JM. The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis. Arch Dis Child 1993; 67: 1086-1068.
28. West SE, Zeng L, Lee BL, et al. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA 2002; 287: 2958-2967.
29. Johansen HK, Norregaard L, Gotzsche P, Pressler T, Koch C, Høiby N. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success? A 30 year cohort study of survival in Danish CF patients after onset of chronic P aeruginosa lung infection. Pediatr Pulmonol 2004; 37: 427-432.
30. Høiby N, Johansen HK, Moser C, Song Z, Ciofu O, Kharazmi A. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 2001; 3: 23-35.